Skip to main content
Clinical Trials/CTRI/2023/11/059678
CTRI/2023/11/059678
Completed
Phase 2

A comparative clinical study to evaluate the efficacy of Agnikarma and Siravyadha in Yakriddalyudara vis-a-vis Fatty liver disease - NI

Dr Megha R0 sites50 target enrollmentTBD

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Health Condition 1: K759- Inflammatory liver disease, unspecified
Sponsor
Dr Megha R
Enrollment
50
Status
Completed
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
July 28, 2024
Last Updated
last year
Study Type
Interventional

Investigators

Sponsor
Dr Megha R

Eligibility Criteria

Inclusion Criteria

  • Sonologically diagnosed case of grade 1 and grade 2 fatty liver disease

Exclusion Criteria

  • Uncontrolled DM and HTN, suffering with other systemic disorders

Outcomes

Primary Outcomes

Not specified

Similar Trials